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http://www.biomedcentral.com/2050-6511/15/65RESEARCH ARTICLE Open AccessUnderuse of medication for circulatory disorders
among unmarried women and men in Norway?
Øystein Kravdal1,2,4* and Emily Grundy3Abstract
Background: It is well established that unmarried people have higher mortality from circulatory diseases and
higher all-cause mortality than the married, and these marital status differences seem to be increasing. However,
much remains to be known about the underlying mechanisms. Our objective was to examine marital status
differences in the purchase of medication for circulatory diseases, and risk factors for them, which may indicate
underuse of such medication by some marital status groups.
Methods: Using data from registers covering the entire Norwegian population, we analysed marital status
differences in the purchase of medicine for eight circulatory disorders by people aged 50-79 in 2004-2008. These
differences were compared with those in circulatory disease mortality during 2004-2007, considered as indicating
probable differences in disease burden.
Results: The unmarried had 1.4-2.8 times higher mortality from the four types of circulatory diseases considered.
However, the never-married in particular purchased less medicine for these diseases, or precursor risk factors of
these diseases, primarily because of a low chance of making a first purchase. The picture was more mixed for the
divorced and widowed. Both groups purchased less of some of these medicines than the married, but, especially in
the case of the widowed, relatively more of other types of medicine. In contrast to the never-married, divorced and
widowed people were as least as likely as the married to make a first purchase, but adherence rates thereafter,
indicated by continuing purchases, were lower.
Conclusion: The most plausible interpretation of the findings is that compared with married people, especially the
never-married more often have circulatory disorders that are undiagnosed or for which they for other reasons
underuse medication. Inadequate use of these potentially very efficient medicines in such a large population group
is a serious public health challenge which needs further investigation. It is possible that marital status differences in
use of medicines for circulatory disorders combined with an increasing importance of these medicines have
contributed to the widening marital status gap in mortality observed in several countries. This also requires further
investigation.
Keywords: Norway, Circulatory disorders, Marital status, Medication, Underuse, Register dataBackground
Numerous studies from many different countries have
shown that married people have lower all-cause mortal-
ity than the unmarried and lower mortality from several
specific causes and cause groups, including circulatory
diseases [1-3]. Health-related and other types of selec-
tion to and from marriage are known to play a role in
this differentiation [4], but marriage is also considered to* Correspondence: okravdal@econ.uio.no
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2Department of Economics, University of Oslo, Oslo, Norway
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article, unless otherwise stated.have health protective effects. These include economic
benefits [5], social support, social control by a spouse
[6,7] and, partly because of this social control, a lower
propensity for risky behaviours [8-10]. These factors
may affect health partly through differences in health-
related behaviours more generally, including participa-
tion in screening programmes, medical consultation
rates and adherence to medication, all of which would
potentially lead to differences in medication use.
Our aim in this paper is to see whether there are dif-
ferences by marital status in the purchase (encashment)Central Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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We also consider incident and continuing purchase of
these medicines. These marital status differences in medi-
cation purchase (assumed to be indicative of medication
use) are compared with marital status differences in mor-
tality from four specific circulatory causes, used as an indi-
cator of probable differences in disease burden. We use
data from registers that cover the entire Norwegian popula-
tion, and in particular the Norwegian Prescription Data-
base, which includes all purchases of prescription medicine
since 2004. The analysis covers the years 2004-2008.
Circulatory diseases are the most common group of
causes of death in high income countries, so such an
analysis of marital status differentials in the use of medi-
cines for these diseases and their risk factors is poten-
tially very important from a public health perspective.
This is particularly the case in the context of improve-
ments in the efficacy of therapeutic treatments for circu-
latory diseases. Advances in drug-based and surgical
treatments have been found to matter greatly at the
population level [11,12] and perhaps explain ¼ to ½ of
the reduction in the mortality from circulatory diseases
over a couple of decades from about 1980 [13-15], and
an American study showed that many years of life are
lost because a large proportion of the population receive
inadequate treatment for coronary heart diseases [16].
Analyses of differentials in medication use by marital
status may thus also shed light on recent increases in
marital status differentials in circulatory disease mortal-
ity, which have contributed strongly to the increases
in the corresponding all-cause mortality differentials
observed in a number of countries [17-19]. In Norway,
especially the never-married have experienced a rising
excess mortality compared to the married [17].
Previous research on marital status differentials in
medication use is sparse and inconclusive. Delayed diag-
nosis or treatment for cardiovascular problems among
unmarried groups has been reported in some studies
[20,21], which accords with studies showing that unmar-
ried people are often diagnosed later with cancer [22,23]
and have lower participation rates in screening for vari-
ous diseases [24]. Differences in adherence to treatments
for various diseases by marital status and availability of
social support have also been reported. For example,
some studies have shown that unmarried people are less
likely to follow doctors’ advice about medication after di-
agnosed coronary diseases [25-28] or hypertension [29],
and adverse changes in health care utilisation among re-
cently widowed chronically ill men have been reported
as well [30]. However, other recent studies of adherence
to treatment for circulatory diseases or conditions (risk
factors) have not found marital status differences
[31,32]. Moreover, the evidence – in either direction - is
generally relatively weak because of small sample sizes[28,29,31] and possible bias arising from use of self-
reported measures of medication adherence [25,29,31],
rather than measures from prescription registers [32] or
electronic monitoring [28].
Methods
Data
The study is based on analysis of two data files, con-
structed (in 2009-2012) from various Norwegian popula-
tion registers. Both include, for everyone who has lived
in Norway since 1960, year of death, immigration and
emigration (if any) and marital status and educational
level at the beginning of each year (since 1980, though
only the information for the years after 2004 was used in
the analysis). These variables were taken from the Cen-
tral Population Register and the Educational Database
(operated by Statistics Norway). Additionally, one of the
files includes information from the Cause-of-death
Register (up to 2007), while the other includes informa-
tion from the Norwegian Prescription Database (NorPD)
for 2004-2008. NorPD covers all purchases of prescrip-
tion medicine (defined by Anatomical Therapeutic
Chemical (ATC) classification) since 2004 by Norwegian
residents, except individuals living in institutions [33].
Because of the latter exclusion, we restricted our analysis
to persons younger than 80 during the period under
study. The lowest age considered is 50. While circulatory
diseases occur among younger individuals, and are
treated medically, there are few deaths from this cause
group at these lower ages.
Separate analyses were undertaken for women and
men, as several studies have suggested that some of the
health benefits of partnership may be sex-specific, espe-
cially in older age groups [34,35]. In all models, we con-
trolled for level of education, which is an important
determinant of marriage and divorce [36,37] as well as
health [38] and health care use [39]. Age was, of course,
also controlled for.
The use of register data for this research purpose has
been approved by the Regional Committees for Medical
and Health Research Ethics and the Norwegian Data
Protection Authority.
Mortality analysis
Discrete time hazard models for all-cause and cause-
specific mortality were estimated for the period 2004-
2007, following standard procedures [40]. A series of one-
year observations was constructed, starting in January
2004, for all those then aged 49-78 and living in the
country. The last observation was the year of death, the
year the person turned 79, the year of emigration, or
2007, whichever came first. Those who became 50 or
immigrated during the observation period were added
from January of the year of their 50th birthday or the
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excluded if the person lived temporarily abroad at the
beginning of the year. Logistic models were estimated
from all remaining observations. In total, there were
35,174 deaths within 2,602,246 person-years of obser-
vation among men and 23,970 deaths within 2,693,670
person-years of observation among women. Table 1
shows the distribution of these by marital status.
The specific causes of death considered are ischemic
heart diseases (ICD-10 codes I00-I25), other heart dis-
eases (I26-I52), cerebrovascular diseases (I60-I69) and all
other circulatory diseases (other I00-I99).
Analyses of medicine purchases: prevalence, incidence
and discontinuation
In the analysis of drug purchases we considered eight
groups of drugs, defined by Kuo et al. [41] as indicating
treatment for specific disorders. These disorders were
(ATC codes shown in notes to Table 2): i) coronary and
peripheral vascular diseases treated with platelet aggre-
gation inhibitors, ii) coronary and peripheral vascular
diseases treated with anticoagulants, iii) hypertension
without any diagnosed heart disease, iv) hyperlipedemia,
v) arrhythmic cardiac diseases, vi) angina, vii) congestive
heart failure (usually in combination with hypertension),
and viii) other ischemic heart diseases (usually in com-
bination with hypertension). The analysis included three
steps. First, logistic models for the chance of purchasing
certain drugs at least once during 2004-2008 (i.e. preva-
lence of medication purchase and, presumably, use) were
estimated, conditional on living in the country at the
beginning and end of that period. There were 579,218
observations for men and 620,911 for women.
In the second step, discrete-time hazard models for
the chance of starting to purchase the specific type of
drug (i.e. incidence) were estimated for those who did
not use it in 2004. More specifically, one-year observa-
tions from 2005 were created conditioned on the indi-
vidual being of age 50-79 that year, being alive both at
the start and the end of the year and not yet havingTable 1 Number of deaths and person-years of exposure in th
2004-2007, by marital status
Never-married
Men
Number of deaths from all causes 5325
Number of deaths from all circulatory diseases 1679
Person-years of exposure 277508
Women
Number of deaths from all causes 2027
Number of deaths from all circulatory diseases 509
Person-years of exposure 175001started to purchase the medicine by the beginning of the
year. The outcome variable was whether the drug was
purchased at least once during the year.
Similarly, in the third step, discrete-time hazard models
for discontinuing the purchase of the medicine were esti-
mated. One-year observations from 2005 were created
conditioned on the individual being of age 50-79 that year,
being alive both at the start and the end of the year, having
purchased the medicine at least once during the preceding
year, but having had no earlier discontinuation of the
purchase of that medicine (i.e. the individual has either
purchased the medicine in every year from 2004 to the
preceding year, or started in 2005 or later and kept
purchasing until at least the previous year). The outcome
variable was whether the drug was purchased at least once
during the year. For simplicity, the signs of the effects
are reversed in the tables and can thus be interpreted as
effects on continuation rather than discontinuation.
Results
Marital status differences in mortality from circulatory
diseases
Mortality from circulatory disease was more than twice
as high among the never-married as among the married
for both men and women. For all circulatory diseases
combined the odds ratio for men was 2.11 (95% CI 1.99-
2.23) and that for women 2.37 (2.15-2.61). Odds ratios
for men and women varied between 1.94 and 2.84 across
the four main sub-categories of circulatory diseases con-
sidered (Table 2). For men the estimates were 1.93-2.52
for the divorced and 1.51-1.75 for the widowed. Similar
results were seen for women, with odds ratios of 1.63-
2.14 for the divorced, and 1.44-1.66 for the widowed.
Associations between marital status and purchase of
medication 2004-2008
Never-married men and women were generally less likely
than the married to purchase medicine for circulatory
disorders (Table 2 and signs shown in Panel A of Table 3).
The only exceptions were that there was no significante mortality analysis of women and men aged 50-79 in
Married Widowed Divorced/separated
19995 3321 6533
6031 1145 2025
1818415 99705 406618
10515 7490 3938
2248 2262 829
1670393 400626 447650
Table 2 Effects of marital status on all-cause and cause-specific mortality (ICD-10 codes in parentheses) 2004-2007a
and the chance of purchasing various types of medicines for circulatory disorders 2004-2008 among women and men
aged 50-79b
Effects of marital status
(with 95% confidence intervals)
Number of deaths
or persons
purchasing
the medicines
Never-married Widowed Divorced/
separated
Men
Mortality from All causes 2.05*** (1.98-2.11) 1.56*** (1.50-1.62) 1.96*** (1.91-2.02) 35174
All circulatory diseases (I00-I99) 2.11*** (1.99-2.23) 1.65*** (1.54-1.75) 2.08*** (1.97-2.18) 10880
Ischemic heart diseases (I20-I25) 1.94*** (1.80-2.10) 1.67*** (1.52-1.82) 1.93*** (1.80-2.07) 5737
Other heart diseases (I26-I52) 2.71*** (2.39-3.08) 1.63*** (1.52-1.82) 2.52*** (2.24-2.85) 1809
Cerebrovascular diseases (I60-I69) 1.99*** (1.75-2.26) 1.51*** (1.31-1.74) 2.07*** (1.84-2.33) 2066
Other circulatory diseases 2.13*** (1.81-2.50) 1.75*** (1.46-2.10) 2.11*** (1.82-2.10) 1268
Purchase of medication
for
Coronary and peripheral vascular
diseases, antiplateletc
0.70*** (0.68-0.73) 1.00 (0.95-1.05) 1.02 (0.99-1.05) 42780
Coronary and peripheral vascular
diseases, anticoagulantd
0.88*** (0.85-0.91) 1.04* (1.00-1.08) 1.03** (1.00-1.06) 59898
Hypertensione 0.98 (0.95-1.01) 1.10*** (1.06-1.15) 0.97*** (0.94-0.99) 56019
Hyperlipedemiaf 0.69*** (0.68-0.71) 0.95*** (0.93-0.98) 0.89*** (0.87-0.90) 185023
Anti-arrhythmic cardiac diseasesg 1.02 (0.97-1.08) 1.09*** (1.03-1.16) 1.09*** (1.04-1.14) 18204
Ischemic heart diseases/anginah 0.75*** (0.73-0.78) 0.98 (0.94-1.02) 0.99 (0.97-1.02) 65918
Congestive heart failure/hypertensioni 0.92*** (0.90-0.94) 1.10*** (1.07-1.32) 0.96*** (0.95-0.98) 195657
Other ischemic heart diseases/hypertensionj 0.88*** (0.86-0.90) 1.08*** (1.05-1.11) 0.96*** (0.94-0.97) 198133
Women
Mortality from All causes 2.05*** (1.95-2.15) 1.40*** (1.35-1.44) 1.70*** (1.64-1.77) 23970
All circulatory diseases (I00-I99) 2.37*** (2.15-2.61) 1.53*** (1.44-1.62) 1.83*** (1.69-1.98) 5848
Ischemic heart diseases (I20-I25) 2.38*** (2.05-2.77) 1.44*** (1.31-1.59) 1.80*** (1.59-2.04) 2323
Other heart diseases (I26-I52) 2.84*** (2.30-3.50) 1.66*** (1.44-1.90) 2.14*** (1.79-2.56) 1163
Cerebrovascular diseases (I60-I69) 2.18*** (1.82-2.61) 1.51*** (1.35-1.69) 1.63*** (1.40-1.91) 1678
Other circulatory diseases 1.94*** (1.43-2.64) 1.63*** (1.36-1.95) 1.91*** (1.36-1.95) 684
Purchase of medication
for
Coronary and peripheral vascular diseases,
antiplatelet c
0.84*** (0.78-0.90) 1.12*** (1.08-1.16) 1.24*** (1.19-1.29) 22058
Coronary and peripheral vascular diseases,
anticoagulantd
0.92*** (0.88-0.96) 1.07*** (1.04-1.10) 1.08*** (1.05-1.11) 51264
Hypertensione 0.96* (0.93-1.00) 1.03*** (1.01-1.06) 0.94*** (0.92-0.97) 58882
Hyperlipedemiaf 0.78*** (0.77-0.81) 0.95*** (0.94-0.97) 0.92*** (0.91-0.94) 175477
Anti-arrhythmic cardiac diseasesg 1.00 (0.92-1.09) 1.08*** (1.03-1.13) 1.07** (1.01-1.14) 11746
Ischemic heart diseases/anginah 0.85*** (0.82-0.89) 1.11*** (1.08-1.13) 1.20*** (1.16-1.23) 52641
Congestive heart failure/hypertensioni 0.95*** (0.93-0.97) 1.07*** (1.06-1.09) 0.99 (0.97-1.01) 203305
Other ischemic heart diseases/hypertensionj 0.87*** (0.85-0.89) 1.03*** (1.01-1.04) 0.94*** (0.92-0.95) 187899
aDiscrete-time hazard models are estimated. The models also include age (in five-year groups), year (in one-year groups), and educational level (in five categories).
*p < 0.10; **p < 0.05; ***p < 0.01.
bLogistic models for the chance of purchasing the medicines are estimated. The models also include age (in five-year groups) and educational level (in five categories).
Medicines are grouped as in Kuo et al. [41]. See details in notes c-j.
cATC codes B01AC, C04AD03 (except B01AC06, B01AC08, B01AC09, B01AC11, B01AC15, B01AC19, B01AC21).
dATC codes B01AA, B01AB, B01AD, B01AX.
eATC codes C02AA02, C02AB02, C02AC, C02BA, C02BB, C02CA, C02CC, C02DA, C02DB, C02DD, C02DG, C03AA, C03AB, C03AX, C03DA, C03DB, C02L.
fATC codes C10AA, C10AB, C10AC, C10AD, C10AX, C10BA, C10BX.
gATC codes C01AA, C01BA, C01BB, C01BC, C01BD, C01BG, C01EB10.
hATC codes C01DA, C01DX16.
iATC codes C01CA07, C01CE01, C01CE02, C01EB09, C03CA, C03CB, C03CC, C09AA, C09BA, C09BB, C09CA, C09DA, C09DB.
jATC codes C07AA, C07AB, C07AG, C07BA, C07BB, C07BG, C07CA, C07CB, C07CG, C07DA, C07DB, C07EA, C07EB, C07FA, C07FB, C08CA, C08CX, C08DA, C08DB,
C08EA, C08EX, C08GA.
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Table 3 Sign and significance (+ and - meaning p <0.10; ++ and - - meaning p <0.05; +++ and - - - meaning p <0.01) of
effects of marital status on the chance of purchasing medicine in 2004-2008, the chance of starting to purchase
medicine 2005-2008, and the chance of continuing with the medicine purchases 2005-2008
Men
Never-
married
Widowed Divorced/separated
Women
Never-
married
Widowed Divorced/separated
Panel A: Purchase of medicine in 2004-2008 (signs as in estimates in Table 2)
Coronary and peripheral vascular diseases, antiplatelet - - - - - - + + + + + +
Coronary and peripheral vascular diseases, anticoagulant - - - + + + - - - + + + + + +
Hypertension + + + - - - - + + + - - -
Hyperlipedemia - - - - - - - - - - - - - - - - - -
Anti-arrhythmic cardiac diseases + + + + + + + + +
IHD/Angina - - - - - - + + + + + +
Congestive heart failure/hypertension - - - + + + - - - - - - + + +
Other IHD/hypertension - - - + + + - - - - - - + + + - - -
Panel B: Starting and continuing purchase of medicine 2005-2008a
Coronary and peripheral vascular diseases, antiplatelet
Start - - - + + + - - - + + + + + +
Continuation + + + + + + + +
Coronary and peripheral vascular diseases, anticoagulant
Start - - - + + + + + + + + +
Continuation - - - +
Hypertension
Start + + + - + + -
Continuation + + + - - - + + - - -
Hyperlipedemia
Start - - - - - - - - -
Continuation - - - - - - - - - - - - - - -
Anti-arrhythmic cardiac diseases
Start + + + + + + + + + + + +
Continuation + + + - -
IHD/Angina
Start - - - - - - + + + + + +
Continuation + + + + + + +
Congestive heart failure/hypertension
Start - - - + + + + + + + + + + +
Continuation - - - - - - - - - - - - - - - - - -
Other IHD/hypertension
Start - - - + + + + + + - - - + + + + +
Continuation - - - - - - - - -
aDiscrete-time hazard models are estimated. The models also include age (in five-year groups), year (in one-year groups), and educational level (in five categories).
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medicine for hypertension (alone) or arrhythmic diseases.
For both sexes, the sharpest negative effects were seen
with respect to drugs for hyperlipidemia.
Among divorced men and women, the purchase of
four types of medicine was lower than in the married
reference group. These were medication for hyper-
tension (alone), hyperlipidemia, heart failure (among
men), and ischemic heart disease. On the other hand,
three types of medicine were purchased to a larger ex-
tent by the divorced than the married, for one or both
sexes: medicine for coronary and peripheral vascular
diseases (antiplatelet as well as anticoagulant treat-
ment), arrhythmic diseases and angina. However, with
two exceptions (1.20 and 1.24), the positive estimates
were not above 1.10.The widowed were, on the whole, more likely than the
married to purchase medicine for circulatory disorders.
There was only one negative relationship: the use of medi-
cine for hyperlipidemia. Relationships with respect to sev-
eral other disorders were positive: hypertension, arrhythmic
diseases, heart failure and ischemic heart disease for both
sexes and coronary and peripheral vascular diseases and an-
gina for women. Again, the positive relationships were not
large; all effects were smaller than 1.12.
Associations between marital status and starting and
continuing drug purchase
The lower chance of purchasing medicine among the
never-married reflects a lower chance of making a first
purchase (Table 3, Panel B). Once initiated, the chance
of continuing to purchase the medication was significantly
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married as the married for several disorders, exceptions
being heart failure and, for men, hyperlipedemia.
For the divorced, who generally purchased about as
much medicine for circulatory disorders as the married,
there is an almost opposite pattern. Their chance of start-
ing to purchase medicine was quite high. This was seen
for several types of medicine for both men and women,
and no effect runs in the other direction. On the other
hand, they had a relatively low probability of continuing to
purchase several types of the medicines considered, and
there was only one example of the opposite.
The pattern for the widowed was similar to that for
the divorced: there were several positive associations
with the chance of starting to purchase medicine and
one negative (as opposed to none for the divorced), and
there was no positive association with the chance of
continuing the purchases (as opposed to one for the
divorced) and several negative ones. However, there were
fewer of the latter associations (five in total, for three
different conditions, as opposed to 10 in total for the
divorced), so on the whole, the widowed appear to be
less different from the married than are the divorced.
Discussion
These results show, consistent with other studies, large
marital status variations in mortality from circulatory
diseases with the highest risks, relative to married
people, for the never-married followed by the divorced
and then the widowed. Overall, in the age group considered
here (50-79), the unmarried had rates of mortality from
circulatory diseases 1.4-2.8 times higher than those of the
married. However, never-married people in particular pur-
chased less of the medicines that are typically used after
such a circulatory disease has been diagnosed or risk factors
for it identified. This was primarily because of a signifi-
cantly lower chance of first purchase of most of these medi-
cines The picture is more mixed for the divorced and
widowed, who purchased less of some of these medicines
but more of others, though the difference in the latter dir-
ection, which was seen especially among the widowed, was
quite small (but statistically significant). In contrast to the
never-married, the chances of starting to purchase these
medicines were as least as high among the divorced and
widowed as among married people, but adherence rates
thereafter, indicated by continuing medication purchases,
were lower (especially among the divorced).
We assume that purchases of medication are good
measures of actual use of medication, and therefore refer
to use in the remaining discussion. To the extent that
there is a difference between purchase and use, it would
seem likely, if anything, that the unmarried might be less
inclined than the married to use the purchased medica-
tion, because of the lack of social support and control bya spouse that is further discussed below. If so, marital
status differences in actual use may be more pronounced
than suggested by our analysis of purchases.
Interpretations of the observed patterns: underuse of
medication?
To draw conclusions about underuse of medicine one
should ideally compare actual use with need or recom-
mended use. Unfortunately, we lack information on the
actual prevalence and severity of the various circulatory
disorders (and associated risk factors), which would be
good indications of the need, and must instead compare
differences in medication purchase, reflecting medication
use, with those in mortality. As mentioned, one of our key
findings is that the never-married use less medicine than
the married for all disorders considered except a few. In
theory, it is possible that they also need less of these medi-
cines, despite their much higher mortality from all circula-
tory disease groups (and thus presumably also from the
disorders under consideration). Let us assume that they to
a larger extent than the married suffer from the most
severe types of each of these disorders, but have a lower
prevalence of the less severe types for which medication is
nevertheless recommended. Then, even if they take
medicine in accordance with recommendations or needs
(i.e. no underuse), they could end up using less medicine
than the married and have higher mortality. In other
words, low usage coupled with high mortality does not ne-
cessarily mean underuse.
However, this situation seems improbable especially as
there are common risk factors for many less and more ser-
ious conditions and evidence from numerous studies points
to a higher, rather than lower, prevalence of circulatory dis-
eases and associated risk factors among the unmarried than
the married. More specifically, it has been shown that the
unmarried have higher cholesterol levels than the married
[42], higher prevalence of diabetes [43,44], and higher blood
pressure [42,45-47], although other studies do not point so
clearly in this direction [48-52]. A modest excess prevalence
of stroke among the unmarried has also been reported
[52,53], as well as an excess prevalence of heart failure [54].
Consistent with this, other studies have reported that life-
style factors associated with higher circulatory disease risks
are less common among married people. In particular, the
unmarried are more likely than the married to be physically
inactive [42,49,50] (but see [55] for an opposite result), to
be obese [49,50,56], (but see [55] for an opposite result) to
have a high intake of sodium [46], to eat more fast food
[55] and to smoke [42,43,49].
Theoretically, the never-married could also have a
lower prevalence of both the more and the less severe
types of any disorder - thus taking less medicine even
without any underuse - and still have a strong mortality
disadvantage because of less adequate use of other types
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However, a study by Bearden et al. [57] that addressed
the latter issue did not show any relationship between
marital status and these kinds of surgical interventions.
To conclude, we think the most plausible interpretation
of our findings is that the unmarried, and especially the
never-married, suffer from circulatory disorders to a lar-
ger extent than the married and therefore have a greater
need for medication, but that they are on the whole less
likely than the married to take the medication they need,
which adds further to their mortality disadvantage.
If the unmarried are particularly inclined to use less
medicine than recommended or needed for their circula-
tory disorders, the implications for mortality depend on
whether this underuse is most pronounced with respect to
the less severe or the more severe types of the disorder.
The use of statins (for hyperlipidemia) may serve as a par-
ticularly relevant example. This drug is used both as pri-
mary prevention (i.e. in the absence of actual circulatory
diseases and even at rather low cholesterol levels if other
risk factors are identified) and secondary prevention (i.e.
when a circulatory disease is diagnosed and presumably
treated). The efficacy of this primary prevention has been
highly disputed, though a recent Cochrane review pointed
towards a mortality reduction [58], which would justify
continuation of the practice. We have found that the
married use more of this medicine than all groups of un-
married, despite the evidence summarised above that sug-
gests higher cholesterol levels for the unmarried and thus
more need for this medicine. Hypothetically, however,
it could be that use of statins among the unmarried for
the purposes of secondary prevention is consistent with
their needs – and so higher than use among the married-
whereas use for the purposes of primary prevention is
much lower. Such a pattern would have fewer implications
for mortality risks than a lower than recommended use
for secondary prevention.
Finally, it should be noted that, if the unmarried to a
larger extent than the married take too little medicine
compared to their needs, they may of course still use
somewhat more medicine per person. For example, we
have found that some groups of unmarried use more
medicine for arrhythmic diseases than the married, and
no group less, which may reflect that there is a particu-
larly large difference between the married and the
unmarried in the actual prevalence of that disorder. The
fact that mortality from “cardiovascular diseases other
than ischemic heart diseases” varies particularly much
according to marital status lends some support to this
idea. Similarly, the unmarried use more diuretics for
heart failure (a subgroup of medicines for that disease
and not shown in the tables), alone or in combination
with other medicine, and this may indicate a relatively
high prevalence of right-sided heart failure, which maybe linked to chronic obstructive pulmonary disease and
thus smoking – the latter being more common among
the unmarried according to some studies as already
noted [42,43,49].
Factors underlying the differentials in use, and likely
underuse, of medication
As mentioned above, studies of marital status differences
in health and mortality consistently refer to economic
benefits of marriage and the important role played by
spouses in providing social support and exerting social
control [5-7]. Such factors are thought to affect the disease
or accident incidence - through lifestyle (including the use
of explicit preventive strategies) - as well as the availability
of care, use of medical treatment and other factors of im-
portance for the further development of the diseases. The
pathway of special relevance given our perspective is that a
spouse’s encouragement and monitoring – but perhaps not
the more favourable economic position of the married -
may affect the chance of seeking a consultation, receiving a
diagnosis (or identifying risk factors) and prescription, cash-
ing the initial prescription, and seeking and cashing further
prescriptions. The reason for the probably modest import-
ance of economic resources is that costs of prescriptions
are typically not very high and for those with chronic
diseases, there are subsidies as well as a cap on total annual
expenses in Norway.
The evidence on such causal pathways is not large, but
some studies of cardiovascular diseases suggest that
spouses may encourage attendance at screening, prompt
consultation after onset of symptoms or otherwise in-
crease the chance of an early diagnosis [20,21]. Consistent
with this, other studies have shown that the unmarried are
often diagnosed later with cancer [22,23] and have lower
participation rates in screening for various diseases [24].
Some, but not all, earlier investigations have also shown a
poorer treatment adherence among the unmarried –
within rather small patient samples and often based on
self-reporting of drug use [26-28,31,32,59], see details in
Introduction. One recent very large study found no differ-
ences between partnered and unpartnered women in
reported use of common medications for IHD two years
after first hospital admission for this condition [60], but it
may be that differences in adherence are less marked for
severe conditions which have resulted in acute admissions.
In the absence of a spouse, children may play a similar
role in supporting consultation and treatment adher-
ence, and as fewer of the never-married than the
widowed or divorced have children, this might account
for some of the differences we found between groups of
the unmarried when it comes to the chance of using
and starting to use the medicines for circulatory disor-
ders. However there is little evidence from previous
studies on this issue. Another possible reason for these
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married is that the latter may persist with habits of
health care seeking developed during their married life,
though it is harder to understand why they are more
inclined to discontinue the use of medicines.
Limitations and strengths of the analysis
The study has some limitations, the most important
being the lack of information on actual disorders as
discussed above. Furthermore, formal marital status does
not tell us the full story about actual living arrange-
ments. Some of the unmarried live in cohabiting unions
(currently 29% in the age group 45-66 and 10% in the
age group 67-79, according to Statistics Norway [61]),
and if cohabitants use medicine to a larger extent than
the unmarried who live alone and do not have a partner,
the difference between the latter and the married will be
even larger than the estimated difference between the
unmarried and the married that we report. Some authors
have shown that the lower prevalence of circulatory
diseases or their risk factors among the married is re-
stricted to those having a good marriage, whereas those
in a poor marriage are in a worse position than the sin-
gle [51,62,63]. With register data, it is of course impos-
sible to consider the quality of the marriage. We also
lacked data on other possibly relevant confounders, me-
diators or moderators such as lifestyle factors, values,
prior health status or indicators of socio-economic status
other than education.
Additionally, NorPD does not include drug purchases
for individuals in health care institutions. Since the un-
married are more likely to be institutionalized, the actual
use of medicine in this group may not be quite as mod-
est compared to the married as indicated by our esti-
mates. However, this bias must be small, as the analysis
only includes persons younger than 80, and at age 75-79
only 5% live in institutions [64].
An important strength of the study is availability of
data that covers the whole population in which the
measure of drug use was based on recorded purchase,
assumed to be a good indicator of use, rather than self-
report of use.
Conclusion
Our results suggest that there is an underuse of medi-
cine for circulatory disorders among the unmarried, and
especially the never-married. The low usage of medica-
tion by the never-married particularly reflects low initial
purchase of medication whereas for the divorced and
widowed failure to continue with medication seemed
more important. Inadequate use of these potentially very
efficient medicines in such a large population group is,
of course, a serious public health problem. Furthermore,
underuse of medication for circulatory disorders amongthe unmarried in relatively recent years, combined with
an increasing importance of such medicines, suggest a
growing disadvantage for the unmarried when it comes to
this type of medication (unless there was a much more
pronounced underuse among these groups in earlier years,
when the available medication was less efficient). This in-
creasing disadvantage may have contributed to their falling
behind with respect to mortality from circulatory diseases,
and thus the widening marital status gap in all-cause
mortality – which has been seen in a number of countries.
In Norway, the excess mortality has increased particularly
much for the group of unmarried also showing the clear-
est indications of underuse of medication for circulatory
disorders, the never-married. Stated differently, the un-
married – and particularly the never-married- may not
have benefited from recent life-saving improvements in
medical treatment for circulatory disorders to the same
extent as the married.
Further investigation of this issue is clearly warranted.
A central element of such investigations should be to
collect data that make it possible to better measure the
potential underuse of medication. For that purpose, one
would need information about the actual prevalence of
the disorders as well as all types of treatment that are
used. Obviously, it would also be an advantage if the
data could shed light on the underlying mechanisms
such as, for example, the role of spouses and children in
prompting seeking of and adherence to treatment.
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